These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria. Forbi JC, Gabadi S, Alabi R, Iperepolu HO, Pam CR, Entonu PE, Agwale SM. Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776 [Abstract] [Full Text] [Related]
12. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients. Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P. Ann Hepatol; 2008 Apr 15; 7(2):152-6. PubMed ID: 18626434 [Abstract] [Full Text] [Related]
13. Epidemiological profile and risk factors of HIV and HBV/HCV co-infection in Fujian Province, southeastern China. Wu S, Yan P, Yang T, Wang Z, Yan Y. J Med Virol; 2017 Mar 15; 89(3):443-449. PubMed ID: 27552721 [Abstract] [Full Text] [Related]
15. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria. Tremeau-Bravard A, Ogbukagu IC, Ticao CJ, Abubakar JJ. Afr Health Sci; 2012 Sep 15; 12(3):312-7. PubMed ID: 23382745 [Abstract] [Full Text] [Related]
16. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL. Clin Infect Dis; 2009 Oct 15; 49(8):1268-73. PubMed ID: 19772386 [Abstract] [Full Text] [Related]